Terns Pharmaceuticals, Inc. (TERN)
48.44
-0.62
(-1.26%)
USD |
NASDAQ |
Mar 20, 16:00
48.76
+0.32
(+0.66%)
After-Hours: 20:00
Terns Pharmaceuticals Research and Development Expense (Quarterly) : 19.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 74.38M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| ADMA Biologics, Inc. | 1.376M |
| Arcellx, Inc. | 34.10M |
| Corcept Therapeutics, Inc. | 64.86M |